Controversy: Botulinum Toxin in Pregnancy

Botulinum toxin A (BTX-A), a purified protein derived from the bacteria Clostridium botulinum, has been widely used in aesthetic dermatology. Though BTX-A was initially used by neurologists extensively for neurological conditions such as blepharospasm, strabismus headaches, dystonia and spasticity,...

Descripción completa

Detalles Bibliográficos
Autor principal: Paul, Munish
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2009
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840916/
https://www.ncbi.nlm.nih.gov/pubmed/20300363
http://dx.doi.org/10.4103/0974-2077.53091
_version_ 1782179045875646464
author Paul, Munish
author_facet Paul, Munish
author_sort Paul, Munish
collection PubMed
description Botulinum toxin A (BTX-A), a purified protein derived from the bacteria Clostridium botulinum, has been widely used in aesthetic dermatology. Though BTX-A was initially used by neurologists extensively for neurological conditions such as blepharospasm, strabismus headaches, dystonia and spasticity, it has become popular among dermatologists and plastic surgeons for its cosmetic indications. Its use in pregnancy has been controversial and this article deals with the issues of use of BTX-A in pregnancy.
format Text
id pubmed-2840916
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Medknow Publications
record_format MEDLINE/PubMed
spelling pubmed-28409162010-03-18 Controversy: Botulinum Toxin in Pregnancy Paul, Munish J Cutan Aesthet Surg Commentary Botulinum toxin A (BTX-A), a purified protein derived from the bacteria Clostridium botulinum, has been widely used in aesthetic dermatology. Though BTX-A was initially used by neurologists extensively for neurological conditions such as blepharospasm, strabismus headaches, dystonia and spasticity, it has become popular among dermatologists and plastic surgeons for its cosmetic indications. Its use in pregnancy has been controversial and this article deals with the issues of use of BTX-A in pregnancy. Medknow Publications 2009 /pmc/articles/PMC2840916/ /pubmed/20300363 http://dx.doi.org/10.4103/0974-2077.53091 Text en © Journal of Cutaneous and Aesthetic Surgery http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Commentary
Paul, Munish
Controversy: Botulinum Toxin in Pregnancy
title Controversy: Botulinum Toxin in Pregnancy
title_full Controversy: Botulinum Toxin in Pregnancy
title_fullStr Controversy: Botulinum Toxin in Pregnancy
title_full_unstemmed Controversy: Botulinum Toxin in Pregnancy
title_short Controversy: Botulinum Toxin in Pregnancy
title_sort controversy: botulinum toxin in pregnancy
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2840916/
https://www.ncbi.nlm.nih.gov/pubmed/20300363
http://dx.doi.org/10.4103/0974-2077.53091
work_keys_str_mv AT paulmunish controversybotulinumtoxininpregnancy

Ejemplares similares